Carmat Sa 1

1. First Clinical Experience With the Pressure Sensor-Based Autoregulation of Blood Flow in an Artificial Heart
2. Bioprosthetic Total Artificial Heart Implantation Does Not Induce Chronic Inflammation
3. Progressive endothelial coverage enhances hemocompatibility and prevents calcification in bioprosthetic valve tissue
4. Precise monitoring of transpulmonic resistance in bridge-to-transplant patients supported by the Aeson total artificial heart
5. Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantation
6. Understanding Platelet Activation in the Aeson Bioprosthetic Total Artificial Heart: Insights From Aspirin Treatment and Outcomes
7. Implantation Technique for the Aeson Total Artificial Heart
1